Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT06930508 · ClinicalTrials.gov registry record · NA
Bringing Medicines for HIV Prevention to a Family Planning Clinic
A NA study, sponsored by Women and Infants Hospital of Rhode Island.
- Recruiting
- Registry status
- NA
- Development phase
- 83
- Enrollment target
NCT06930508 is a NA study that is actively recruiting participants, run by Women and Infants Hospital of Rhode Island. The registered enrollment target is 83 participants.
The verdict
NCT06930508, a NA study, is actively recruiting participants, sponsored by Women and Infants Hospital of Rhode Island.
- RECRUITING
- Registry status
- NA
- Development phase
- 83 participants
- Enrollment target
Study Summary
The goal of this clinical trial is to understand what patients and physicians think about providing medications to prevent HIV transmission to patients in a family planning clinic. These medications are known as pre-exposure prophylaxis, or PrEP. The main questions to answer are: 1. Do patients find it acceptable to be asked about, and offered, PrEP during their visit to a family planning clinic? 2. What things make it easier or harder to ask about PrEP in a family planning clinic setting? 3. What things make it easier or harder to begin PrEP in a family planning clinic setting? Patient participants: 1. Will receive standardized counseling about PrEP. 2. Will have the opportunity to begin PrEP as part of their routine, ongoing care. 3. Will be asked to complete a survey about their experiences. Physician participants: 1. Will receive standardized education about PrEP. 2. Will talk to patient participants about PrEP, and support patient participants who want to begin PrEP. 3. Will be asked to complete pre-and post-study surveys about their experiences. 4. May be asked to complete a post-study in-depth interview about their experiences.
Interventions
- BEHAVIORAL Patient participant screening
- BEHAVIORAL Physician participant training
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 83 participants |
| Start Date | 2026-05-28 |
| Est. Completion | 2026-07-31 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT06930508
The ClinicalTrials.gov registry entry for NCT06930508 describes a study currently listed as recruiting, categorized as NA. The registered enrollment target is 83 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Women and Infants Hospital of Rhode Island, which has 65 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 2 interventions - of which Patient participant screening is the first listed.
NCT06930508 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT06930508 about?
NCT06930508 is a clinical study titled "Bringing Medicines for HIV Prevention to a Family Planning Clinic". The goal of this clinical trial is to understand what patients and physicians think about providing medications to prevent HIV transmission to patients in a family planning clinic. These medications are known as pre-exposure prophylaxis, or PrEP. The main questions to answer are: 1. Do patients fin...
What is the current status of trial NCT06930508?
This trial is currently recruiting. It is a NA study. The enrollment target is 83 participants. The study started on 2026-05-28. Estimated completion is 2026-07-31.
What interventions are being tested in trial NCT06930508?
The interventions under investigation include: Patient participant screening (BEHAVIORAL), Physician participant training (BEHAVIORAL).
Who is sponsoring clinical trial NCT06930508?
This trial is sponsored by Women and Infants Hospital of Rhode Island, which has 65 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.